Oramed Pharmaceuticals Inc. (ORMP) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 118M |
| Enterprise Value | 72.88M |
| P/E Ratio | 1.49 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.69 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 1.92 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | 0.41 |
| Return On Equity | 0.55 |
Income Statement
| Revenue | 2M |
| Revenue/Share | 0 |
| Gross Profit | 13,000 |
| EBITDA | 75.44M |
| Net Income | 64.05M |
| Diluted EPS | 1.5 |
Balance Sheet
| Total Cash | 65.84M |
| Total Cash/Share | 1.61 |
| Total Debt | 761,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 6.45 |
| Book Value Per Share | 5.84 |
Price History
| 52-Week Change | 90.05 |
| 52-Week High | 5.01 |
| 52-Week Low | 1.98 |
| Moving Average 50 Days | 3.96 |
| Moving Average 200 Days | 3.17 |
Statistics
| Average Volume | 161,930 |
| Shares Outstanding | 40.93M |
| % Held by Institutions | 31.98 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.25 |
| Trailing Annual Dividend Yield | 6.23 |
| Payout Ratio | 0 |
| Last Split Factor | 1:12 |
| Last Split Date | January 23, 2013 |
AD
